Satoshi Kodama

Satoshi Kodama

Auto-generated profile, based on publicly available information

Satoshi Kodama

Department of Neurology, The University of Iowa Hospitals and Clinics, Iowa, United States

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in Brain Stimulation
Verified
Journal Article
Closed access
TSTakuya Sasaki
Takuya Sasaki
SKSatoshi Kodama
Satoshi Kodama
NTNaohiko Togashi
Naohiko Togashi
YSYuichiro Shirota
Yuichiro Shirota
YSYusuke Sugiyama
Yusuke Sugiyama
MHMasashi Hamada
Masashi Hamada

1 January 2019 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
KKKazuto Katsuse
Kazuto Katsuse
MKMasanori Kurihara
Masanori Kurihara
YSYusuke Sugiyama
Yusuke Sugiyama
SKSatoshi Kodama
Satoshi Kodama
MTMiwako Takahashi
Miwako Takahashi
TTTatsushi Toda
Tatsushi Toda

1 May 2017 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
SKSatoshi Kodama
Satoshi Kodama
TMTatsuo Mano
Tatsuo Mano
AMAkihiro Masuzawa
Akihiro Masuzawa
YHYasutaka Hirata
Yasutaka Hirata
YNYuki Nagasako
Yuki Nagasako
STShoji Tsuji
Shoji Tsuji

1 November 2018 in Brain Stimulation
Verified
Journal Article
Closed access
TSTakuya Sasaki
Takuya Sasaki
YSYuichiro Shirota
Yuichiro Shirota
SKSatoshi Kodama
Satoshi Kodama
NTNaohiko Togashi
Naohiko Togashi
YSYusuke Sugiyama
Yusuke Sugiyama
MHMasashi Hamada
Masashi Hamada

15 December 2024 in Internal Medicine
Verified
Journal Article
Open access
PDF file
YNYumiko Nakamura
Yumiko Nakamura
MUMasayuki Ueda
Masayuki Ueda
SKSatoshi Kodama
Satoshi Kodama
TKTomohiko Kimura
Tomohiko Kimura
YSYuichiro Shirota
Yuichiro Shirota
TTTatsushi Toda
Tatsushi Toda
A 35-year-old woman with no prior history of epilepsy developed status epilepticus (SE), which was highly resistant to multiple antiseizure medications and sedatives. The etiology of SE was not identified despite extensive investigation, and the patient was diagnosed with cryptogenic new-onset refractory status epilepticus (C-NORSE). Although first-line immunotherapies such as high-dose corticosteroids and plasma exchange were ineffective, the patient manifested a resolution of SE after the administration of tocilizumab, which inhibits interleukin-6. Non-antibody-mediated inflammation has been hypothesized to be a probable pathophysiology of C-NORSE in recent studies, and tocilizumab may be a plausible second-line treatment.

1 January 2019 in Clinical Neurophysiology Practice
Verified
Journal Article
Open access
SKSatoshi Kodama
Satoshi Kodama
YSYuichiro Shirota
Yuichiro Shirota
AHAkifumi Hagiwara
Akifumi Hagiwara
JOJuuri Otsuka
Juuri Otsuka
KSKazuya Sato
Kazuya Sato
TTTatsushi Toda
Tatsushi Toda
Multinodular and vacuolating neuronal tumor (MVNT) had been initially described as an epilepsy-related brain tumor, but recent studies demonstrated it could be found incidentally in non-epilepsy patients. A 33-year-old woman with intractable post-encephalitis epilepsy presented a cluster of multinodular T2 hyperintensity in the left temporal lobe, which was very similar to the characteristics of MVNT. Long-term video electroencephalogram demonstrated that the habitual seizures were originated from bilateral temporal area and the interictal epileptic discharges were seen multifocally, although the lesions with MVNT appearance were localized in the left temporal lobe. It was presumed that the epilepsy in this patient was due to encephalitis in the past, and the link between the lesions and the epilepsy in this patient seemed weak. Although MVNT had been considered as an epilepsy-related brain tumor, we suggest it is not necessarily preferable to perform surgical resection of MVNT even on patients with epilepsy, unless epileptic foci are highly related to MVNT.